Concepedia
2
Publications
22
Citations
H-Index
2024
Active since
Affiliations
The Netherlands Cancer Institute(Current)
The University of Texas MD Anderson Cancer Center
X. Le is an author at The Netherlands Cancer Institute.
Publications per year
2024–2025
1O: Osimertinib (osi) + datopotamab deruxtecan (Dato-DXd) in patients (pts) with EGFR-mutated (EGFRm) advanced NSCLC (aNSCLC) whose disease progressed on first-line (1L) osi: ORCHARD
X. Le, L. Hendriks, Alessandro Morabito et al. · Journal of Thoracic Oncology · 2025 · 12 citations · Full text
PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations
X. Le, Y. Zhao, D. Planchard et al. · Journal of Thoracic Oncology · 2024 · 10 citations · Full text
Rows per page
1–2 of 2